Kotrova, Michaela
Volland, Antonia
Kehden, Britta
Trautmann, Heiko
Ritgen, Matthias
Wäsch, Ralph http://orcid.org/0000-0002-0813-3444
Faul, Christoph
Viardot, Andreas
Schwartz, Stefan
Baldus, Claudia D.
Gökbuget, Nicola
Brüggemann, Monika
Article History
Received: 8 March 2019
Revised: 18 July 2019
Accepted: 16 August 2019
First Online: 22 October 2019
Compliance with ethical standards
:
: NG: Consultancy for Amgen, Pfizer, Novartis, Celgene, Kite/Gilead; Travel support and Research Funding for Amgen, Pfizer, Novartis. SS: Speaker honoraria, travel grant from: Basilea Pharmaceutica, Gilead, MSD Sharp & Dohme, Pfizer; Advisory Board of: Basilea Pharmaceutica, BTG International Inc., Gilead, MSD Sharp & Dohme; Travel grant: BTG International Inc.; Reimbursement for treatment and monitoring of study participants: GlaxoSmithKline. MB: contract research for Affimed, Amgen, Regeneron, advisory board of Amgen, Incyte; speaker bureau of Janssen, Pfizer, Roche. AVi: Advisory board: Pfizer, Roche, Amgen, Kite/Gilead; Honoraria: Pfizer, Roche; Travel grants: Kite/ Gilead, Roche, Abbvie, Janssen. The remaining authors declare that they have no conflict of interest.